Should we be testing for urogenitalMycoplasma hominis,Ureaplasma parvumandUreaplasma urealyticumin men and women? – a position statement from the EuropeanSTIGuidelines Editorial Board-Reference-Cited by-同舟云学术

Should we be testing for urogenitalMycoplasma hominis,Ureaplasma parvumandUreaplasma urealyticumin men and women? – a position statement from the EuropeanSTIGuidelines Editorial Board

Published:2018-07-06 Issue:11 Volume:32 Page:1845-1851
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Horner P.¹²,Donders G.³,Cusini M.⁴,Gomberg M.⁵,Jensen J.S.⁶,Unemo M.⁷

Affiliation:

1. Population Health Sciences Bristol Medical School University of Bristol Bristol UK

2. National Institute for Health Research Health Protection Research Unit in Evaluation of Interventions University of Bristol Bristol UK

3. Department of Obstetrics and Gynecology University Hospital Antwerp Edegem Belgium

4. Department of Dermatology Fondazione IRCCS Ca’ Granda Ospedale Policlinico Milano Italy

5. Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology Moscow Russia

6. Infection Preparedness Research Unit for Reproductive Tract Microbiology Statens Serum Institut Copenhagen Denmark

7. Department of Laboratory Medicine, Microbiology World Health Organization Collaborating Centre for Gonorrhoea and Other STIs Faculty of Medicine and Health Örebro University Örebro Sweden

Funder

National Institute for Health Research

Public Health England

World Health Organization

European Centre for Disease Prevention and Control

Universitetssjukhuset Örebro

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.15146